The company has aggressively deleveraged, reducing total debt from a peak of $52.2M in 2022Q2 to $4.7M in 2026Q2, while retained earnings remain deeply negative at -$63.4M.
| Metric | TTM | Mar'25 | Mar'24 | Mar'23 | Mar'22 | Mar'21 | Mar'20 | Mar'19 | Mar'18 | Mar'17 | Mar'16 | Mar'15 | Mar'14 | Mar'13 | Mar'12 | Mar'11 | Mar'10 | Jul'08 | Jul'07 |
|---|
| Total Current Assets | 56.74M | 59.71M | 69.68M | 64.48M | 75.36M | 72.23M | 60.99M | 56.2M | 62.32M | 55.96M | 46.88M | 42.29M | 27.73M | 45.16M | 47.85M | 39.46M | 15.01M | 1.61K | 30.35K |
| Cash & Short-Term Investments | 13.94M | 12.78M | 20.15M | 18.81M | 18.46M | 22.14M | 16.33M | 9.5M | 15.31M | 18.45M | 7.14M | 5.33M | 4.45M | 4.52M | 3.83M | 6.49M | 801.59K | 1.61K | 30.35K |
| Cash Only | 13.94M | 12.78M | 20.15M | 18.81M | 18.46M | 22.05M | 16.18M | 9.32M | 15.13M | 18.36M | 6.67M | 4.02M | 4.45M | 4.52M | 3.83M | 6.49M | 801.59K | 1.61K | 30.35K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 91.47K | 157.16K | 180.93K | 175.14K | 87.07K | 465.17K | 1.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 26.45M | 30.23M | 19.08M | 16.84M | 22.5M | 18.52M | 14.9M | 13.31M | 11.7M | 11.08M | 9.45M | 10.51M | 6.88M | 13.14M | 17.12M | 2.53M | 1.51M | 0 | 0 |
| Days Sales Outstanding | 33.65 | 91.98 | 45.05 | 41.32 | 49.96 | 50.76 | 46.34 | 45.16 | 44.43 | 49.64 | 38.71 | 49.87 | 37.98 | 53.58 | 66.23 | 13.22 | 9.99 | - | - |
| Inventory | 10.51M | 9.76M | 16.25M | 15.31M | 16.02M | 16.97M | 12.25M | 13.96M | 13.43M | 9.92M | 10.8M | 10.54M | 7.05M | 8.59M | 6.88M | 4.62M | 3.77M | 0 | 0 |
| Days Inventory Outstanding | 21.67 | 30.67 | 48.05 | 48.79 | 45.73 | 59.63 | 48.69 | 61.78 | 64.51 | 55.83 | 55.1 | 59.68 | 42.57 | 41.87 | 37.57 | 34.52 | 35.95 | - | - |
| Other Current Assets | 5.84M | 6.51M | 12.78M | 12.85M | 16.96M | 12.75M | 14.97M | 15.51M | 16.32M | 9.43M | 13.75M | 8.99M | 3.13M | 2.41M | 3.22M | 1.47M | 2.08M | 0 | 0 |
| Total Non-Current Assets | 4.65M | 4.78M | 25.37M | 26.49M | 31.03M | 34.08M | 38.53M | 16.53M | 11.49M | 11.21M | 15.19M | 17.22M | 18.18M | 22.68M | 27.11M | 14.48M | 9.01M | 0 | 0 |
| Property, Plant & Equipment | 7.09K | 8.93K | 18.73M | 19.03M | 19.66M | 23.33M | 29.35M | 8.73M | 4.08M | 5.44M | 8.14M | 9.79M | 12.29M | 18.71M | 21.18M | 5.47M | 1.19M | 0 | 0 |
| Fixed Asset Turnover | 29.42x | 13433.17x | 8.25x | 7.82x | 8.36x | 5.71x | 4.00x | 12.32x | 23.56x | 14.98x | 10.94x | 7.85x | 5.38x | 4.78x | 4.45x | 12.79x | 46.51x | - | - |
| Goodwill | 1.46M | 1.46M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.62K | 0 | 0 | 1.47M | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.18M | 3.3M | 3.65M | 3.89M | 4.37M | 4.38M | 4.44M | 4.79M | 4.06M | 2.71M | 2.93M | 3.12M | 1.57M | 1.2M | 1.35M | 6.47M | 0 | 0 | 0 |
| Long-Term Investments | 2.43M | 0 | 1.2M | 1.77M | 4.51M | 3.98M | 2.54M | 24.24K | 40.89K | 46.15K | 108.54K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 1.8M | 1.8M | 2.48M | 2.38M | 2.2M | 2.98M | 3.32M | 3.01M | 4.01M | 4.29M | 4.32M | 2.77M | 3.12M | 2.54M | 7.82M | 0 | 0 |
| Total Assets | 61.39M | 64.48M | 95.06M | 90.97M | 106.38M | 106.31M | 99.52M | 72.73M | 73.81M | 67.17M | 62.07M | 59.51M | 45.91M | 67.84M | 74.96M | 53.93M | 24.02M | 1.61K | 30.35K |
| Asset Turnover | 3.28x | 1.86x | 1.63x | 1.64x | 1.55x | 1.25x | 1.18x | 1.48x | 1.30x | 1.21x | 1.43x | 1.29x | 1.44x | 1.32x | 1.26x | 1.30x | 2.30x | - | - |
| Asset Growth % | -63.11% | -32.16% | 4.49% | -14.49% | 0.07% | 6.83% | 36.83% | -1.47% | 9.88% | 8.22% | 4.31% | 29.62% | -32.33% | -9.5% | 38.98% | 124.56% | 1495379.27% | -94.71% | - |
| Total Current Liabilities | 31.12M | 34.36M | 74.36M | 66.54M | 74.45M | 64.9M | 57.44M | 55.21M | 54.81M | 40.01M | 42.12M | 41.96M | 31.27M | 29.67M | 22.58M | 11.72M | 7.33M | 0 | 0 |
| Accounts Payable | 21.85M | 19.67M | 31.63M | 26.99M | 27.33M | 29.9M | 21.56M | 23.11M | 25.26M | 19.44M | 16.67M | 15.92M | 14.55M | 13.78M | 13.91M | 3.53M | 2.33M | 0 | 0 |
| Days Payables Outstanding | 41.36 | 61.81 | 93.53 | 86.02 | 78.01 | 105.03 | 85.72 | 102.3 | 121.33 | 109.39 | 85.02 | 90.13 | 87.92 | 67.19 | 76 | 26.39 | 22.22 | - | - |
| Short-Term Debt | 4.66M | 10.39M | 31.95M | 29.26M | 36.15M | 28.98M | 30.3M | 25.95M | 19.18M | 12.69M | 17.63M | 15.79M | 8.28M | 7.19M | 4.21M | 2.7M | 2.34M | 0 | 0 |
| Deferred Revenue (Current) | 1.26M | 264.07K | 518.24K | 695.93K | 1.87M | 1.15M | 708.14K | 771.94K | 4.04M | 2.68M | 2.61M | 3.76M | 3.19M | 4.83M | 1.33M | 2.04M | 0 | 0 | 0 |
| Other Current Liabilities | 4.61M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 1.82x | 1.74x | 0.94x | 0.97x | 1.01x | 1.11x | 1.06x | 1.02x | 1.14x | 1.40x | 1.11x | 1.01x | 0.89x | 1.52x | 2.12x | 3.37x | 2.05x | - | - |
| Quick Ratio | 1.49x | 1.45x | 0.72x | 0.74x | 0.80x | 0.85x | 0.85x | 0.77x | 0.89x | 1.15x | 0.86x | 0.76x | 0.66x | 1.23x | 1.81x | 2.97x | 1.53x | - | - |
| Cash Conversion Cycle | 13.96 | 60.83 | -0.43 | 4.09 | 17.67 | 5.36 | 9.32 | 4.65 | -12.39 | -3.91 | 8.8 | 19.42 | -7.36 | 28.26 | 27.81 | 21.35 | 23.72 | - | - |
| Total Non-Current Liabilities | 484.78K | 492.12K | 6.4M | 7.77M | 9.2M | 17.01M | 23.3M | 547.18K | 138.8K | 496.22K | 636.3K | 315.33K | 278.92K | 15.61K | 34.42K | 153.23K | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 1.89M | 4.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 12.94M | 0 | 6.4M | 7.77M | 9.2M | 15.12M | 19.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 492.12K | 492.12K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 484.78K | 0 | 0 | 0 | 0 | 0 | 134.6K | 547.18K | 138.8K | 496.22K | 636.3K | 315.33K | 278.92K | 15.61K | 34.42K | 153.23K | 0 | 0 | 0 |
| Total Liabilities | 31.61M | 34.85M | 80.76M | 74.3M | 83.65M | 81.91M | 80.74M | 55.76M | 54.95M | 40.51M | 42.76M | 42.28M | 31.54M | 29.69M | 22.61M | 11.87M | 7.33M | 0 | 0 |
| Total Debt | 4.66M | 10.39M | 43.22M | 42.16M | 48.67M | 46.78M | 54.45M | 25.95M | 19.18M | 12.69M | 17.63M | 15.79M | 8.28M | 7.19M | 4.21M | 2.7M | 2.34M | 0 | 0 |
| Net Debt | -9.27M | -2.39M | 23.07M | 23.35M | 30.22M | 24.74M | 38.27M | 16.63M | 4.05M | -5.67M | 10.95M | 11.76M | 3.83M | 2.66M | 375.71K | -3.79M | 1.54M | -1.61K | -30.35K |
| Debt / Equity | 0.16x | 0.35x | 3.02x | 2.53x | 2.14x | 1.92x | 2.90x | 1.53x | 1.02x | 0.48x | 0.91x | 0.92x | 0.58x | 0.19x | 0.08x | 0.06x | 0.14x | - | - |
| Debt / EBITDA | 2.67x | 2.09x | 23.36x | - | - | - | - | 32.43x | - | - | 12.32x | 3.49x | - | - | 0.33x | - | 0.18x | - | - |
| Net Debt / EBITDA | -5.31x | -0.48x | 12.47x | - | - | - | - | 20.78x | - | - | 7.65x | 2.60x | - | - | 0.03x | - | 0.12x | - | - |
| Interest Coverage | - | - | -305.63x | -314.00x | -7.00x | -17.33x | -8.22x | - | - | -4120.44x | 4.50x | - | - | - | - | 485.08x | 196.38x | - | - |
| Total Equity | 29.78M | 29.64M | 14.29M | 16.67M | 22.74M | 24.4M | 18.78M | 16.97M | 18.86M | 26.66M | 19.32M | 17.23M | 14.36M | 38.15M | 52.35M | 42.06M | 16.69M | 1.61K | 30.35K |
| Equity Growth % | 155.83% | 107.35% | -14.24% | -26.7% | -6.82% | 29.95% | 10.65% | -10.03% | -29.26% | 38.04% | 12.08% | 19.98% | -62.35% | -27.13% | 24.46% | 152.03% | 1039112.27% | -94.71% | - |
| Book Value per Share | 114536.90 | 120473.10 | 223330.27 | 724658.78 | 999999.00 | 999999.00 | 999999.00 | 999999.00 | 999999.00 | 999999.00 | 999999.00 | 999999.00 | 999999.00 | 999999.00 | 999999.00 | 999999.00 | 999999.00 | - | - |
| Total Shareholders' Equity | 29.78M | 29.64M | 15.64M | 18.01M | 24.09M | 25.74M | 20.59M | 18.17M | 18.86M | 26.66M | 19.32M | 17.19M | 14.32M | 38.15M | 52.35M | 42.06M | 16.69M | 1.61K | 30.35K |
| Common Stock | 5.86K | 1.41M | 418.41K | 284.37K | 41.75K | 41.75K | 32.94K | 28.94K | 28.94K | 25.21K | 17.74K | 15.65K | 14.42K | 13.61K | 13.59K | 13.53K | 10K | 4.2K | 4.2K |
| Retained Earnings | -63.37M | -63.31M | -73.51M | -69.27M | -48.13M | -44.94M | -36.4M | -30.59M | -29.66M | -12.6M | -6.96M | -7.4M | -8.26M | 17.1M | 31.43M | 23.29M | 16.16M | -32.48K | -3.74K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 4.17K | -199.2K | 2.31M | 3.04M | 5.66M | 4.13M | 2.75M | 3.82M | 4.9M | 2.66M | 4.17M | 5.28M | 5.21M | 4.43M | 4.06M | 2.43M | -362.26K | -32.48K | 0 |
| Minority Interest | 0 | 0 | -1.35M | -1.35M | -1.35M | -1.34M | -1.81M | -1.19M | 0 | 0 | 0 | 39.06K | 40.54K | -1.88K | -1.07K | 0 | 0 | 0 | 0 |
Regulatory-driven business model collapse
As reported in recent financial statements, Ridgetech's total assets have plummeted from $116.9M in 2022Q2 to $61.4M by 2026Q2, reflecting a significant downsizing of the company's operational footprint and a potential loss of market relevance within the Chinese medical distribution sector.
The consistent reduction in total assets suggests that the company is liquidating or failing to replace its core operating base as revenue contracts. This trajectory indicates that the business is shrinking rather than optimizing, which may limit its future capacity to compete for large-scale procurement tenders.
Based on quarterly filings, Ridgetech has aggressively reduced its total debt from a peak of $52.2M in 2022Q2 to just $4.7M in 2026Q2, a shift that appears to be a forced response to shrinking operational scale rather than a strategic capital allocation decision.
While the reduction in debt-to-equity from 2.14 to 0.16 improves the headline leverage profile, it likely reflects a loss of access to credit markets or a deliberate move to minimize interest expenses amidst declining revenue. Investors should monitor whether this low leverage limits the company's ability to finance the working capital required for inventory procurement.
According to the latest balance sheet data, Ridgetech maintains a current ratio of 1.82, yet this liquidity position is supported by a shrinking asset base and $13.9M in cash that may be insufficient to cover long-term operating deficits in a high-volume, low-margin environment.
The current ratio improvement appears to be a byproduct of debt repayment and asset liquidation rather than improved cash generation. Given the negative operating margins, this cash buffer may be rapidly consumed, leaving the company with limited flexibility to navigate further regulatory shocks or supply chain disruptions.
As indicated by historical balance sheet data, Ridgetech's retained earnings have remained deeply negative, reaching -$63.4M in 2026Q2, which highlights a persistent inability to generate sustainable shareholder value despite the company's long-term presence in the medical distribution market.
The persistent deficit in retained earnings suggests that the company has been unable to achieve the economies of scale necessary to offset its fixed cost structure. This ongoing erosion of equity warrants further investigation into whether the company will require future capital injections to remain a going concern.
Based on the provided financial data, the near-total disappearance of net PPE, which fell from $24.8M in 2022Q2 to a negligible $7.1K in 2026Q2, suggests that the company has effectively divested its physical infrastructure, potentially signaling a pivot away from core distribution capabilities.
The collapse in PPE value is a non-obvious risk that implies the company may no longer possess the physical logistics assets required to maintain its regional distribution network. This shift raises questions about the company's long-term operational viability and whether it is transitioning into a hollowed-out entity.
Quick answers to the most common questions about buying RDGT stock.
As of 2025, Ridgetech Inc. (RDGT) had total assets of $64.5M including $59.7M in current assets.
Ridgetech Inc. (RDGT) carries total debt of $10.4M, offset by $12.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Ridgetech Inc. (RDGT) has total shareholders' equity (book value) of $29.6M ($120473.10 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Ridgetech Inc. (RDGT) reported a current ratio of 1.74x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.